ST. LOUIS, Nov. 9, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) today announced its intention to release its 2018 financial guidance on Thursday, December 14, 2017, via press release before the market opens, followed by a conference call to discuss the 2018 financial guidance at 8:30 a.m. Eastern Time (7:30 a.m. Central Time) on Thursday, December 14, 2017. The conference call will feature remarks by Tim Wentworth, President and CEO, and Jim Havel, CFO.
The call will include a slide presentation and is being webcast and can be accessed at the Investor Relations section of Express Scripts' website at http://www.express-scripts.com/corporate. RealPlayer or Windows Media Player is needed to listen to the webcast and free downloads of these players are available at the broadcast site. Both the slide presentation and the webcast will remain available on the Investor Relations section of Express Scripts' website for 90 days.
About Express Scripts
Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.
Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.
View original content:http://www.prnewswire.com/news-releases/express-scripts-holding-company-announces-2018-financial-guidance-conference-call-300553242.html
SOURCE Express Scripts
Jim Havel, Chief Financial Officer, Ben Bier, Vice President, Investor Relations, (314) 810-3115, email@example.com